CRP and COVID-19: In our study of patients with COVID-19 with good and poor outcomes, a serial assessment of such blood-cell-count-related and CRP-related inflammatory markers as lymphocyte to monocyte ratio (LMR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein to lymphocytes ratio (CLR), aggregate index of systemic inflammation (AISI), multi-inflammatory index (MII), systemic inflammatory index (SII), and systemic inflammation response index (SIRI) was performed.